Omar Ishrak has his work cut out for him. Not only does he have to figure out a way to rejuvenate a business whose biggest division has slowed down and deal with regulatory pressures on the device ...

In response to their prior inquiries, Medtronic Spine President Douglas King wrote letters to Minnesota Senators Al Franken and Amy Klobuchar, stating the adverse events that occurred during a study ...

Medtronic has been making significant strides in its Cranial & Spinal Technologies (CST) business unit recently.

Medtronic has agreed to settle, for a total of about $22 million and without admitting any liability, the claims of about 950 plaintiffs in the continuing series of lawsuits over their Infuse bone ...

WASHINGTON (AP) — Medical device maker Medtronic Inc. helped write and edit medical journal articles attributed to outside physicians, which downplayed the risks of the company’s best-selling bone ...

Medtronic issued the following statement in response to a Star Tribune article on the company's Infuse medical device. Read the original article here. Medtronic Responds to Star Tribune Article ...

(Reuters) - Medtronic Inc said it agreed to pay $85 million to settle a shareholder lawsuit accusing it of making misleading statements concerning Infuse, a genetically engineered bone graft used in ...

In a short news release issued Wednesday afternoon, Medtronic (NYSE:MDT) disclosed that the U.S. Department of Justice has closed its civil and criminal investigation into the company’s former ...

BOSTON — Medtronic Plc has agreed to pay $12 million to resolve claims that the company engaged in a deceptive marketing strategy to promote its Infuse bone graft product used in spinal surgery, the ...

NEW YORK (AP) — Medical device maker Medtronic Inc. has agreed to pay $85 million to resolve a federal class action lawsuit brought by a group of shareholders. In December 2008, the Minneapolis ...